Computer-aided drug design: the next 20 years

@article{Drie2007ComputeraidedDD,
  title={Computer-aided drug design: the next 20 years},
  author={John H. Van Drie},
  journal={Journal of Computer-Aided Molecular Design},
  year={2007},
  volume={21},
  pages={591-601}
}
  • J. V. Drie
  • Published 2007
  • History, Computer Science
  • Journal of Computer-Aided Molecular Design
This perspectives article has been taken from a talk the author gave at the symposium in honor of Yvonne C. Martin’s retirement, held at the American Chemical Society spring meeting in Chicago on March 25, 2007. The talk was intended as a somewhat lighthearted attempt to gaze into the future; inevitably, in print, things will come across more seriously than was intended. As we all know—the past is rarely predictive of the future. 
The evolution of drug design at Merck Research Laboratories
TLDR
How the Merck drug design group crafted a new strategy, defined the appropriate phenotype for group members, developed the right skillsets, and identified metrics for success in order to drive continuous improvement is discussed. Expand
3d Enantioselective Descriptors for Ligand-based Computer-aided Drug Design
4. ROC and PPV results for the feature forward analysis with the control set of features compared with the control set combined with EMAS features .. Introduction On October 5, 1981, Fortune magazineExpand
What is next for small-molecule drug discovery?
TLDR
In recent years, several alternative strategies have appeared in the form of the emerging paradigms of polypharmacology, systems biology and personalized medicine, which point to key challenges and breakthroughs likely to affect the future of small-molecule drug discovery. Expand
An Overview of Molecular Modeling for Drug Discovery with Specific Illustrative Examples of Applications
TLDR
The current status of high-performance computing applications in the general area of drug discovery is reviewed and an introduction to the methodologies applied at atomic and molecular scales is provided, followed by three specific examples of implementation of these tools. Expand
Receptor-based virtual screening protocol for drug discovery.
TLDR
This chapter provides a comprehensive overview of the receptor-based virtual screening process and of its importance in the present drug discovery and development paradigm. Expand
Role of Computer Aided Drug Design in Drug Development and Discovery : An Overview
The process of drug development and discovery is very challenging, expensive and time consuming. It has been accelerated due to development of computational tools and methods. Over the last fewExpand
The Significance of Discovery Screening and Structure Optimization Studies
Selection of appropriate tools for optimizing the functionality and viability of early drug candidates in early drug discovery research is the key to the development of effective therapeutic agents.Expand
Drug Discovery: An In Silico Approach
The field of drug research, guided by chemistry, pharmacology, and clinical sciences, has been a major contributor in progressing and development of medicine during the past century. The arrival ofExpand
Case studies on computer-based identification of natural products as lead molecules
TLDR
The importance of the chemical diversity of NPs as a source for potential drugs as well as some of the success stories of NP-derived candidates against important therapeutic targets are highlighted. Expand
The in silico drug discovery toolbox: applications in lead discovery and optimization.
TLDR
The early steps of drug-discovery pipeline are analysed, describing the sequence of steps from disease selection to lead optimization and focusing on the most common in silico tools used to assess attrition risks and build a mitigation plan. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Three-dimensional molecular modeling and drug design.
TLDR
The computer-assisted molecular modeling system at Merck is described, and it is shown that this system is useful for generating and storing molecular structures, determining preferred conformation, comparing molecular shapes, and computing molecular properties. Expand
De novo design of enzyme inhibitors by Monte Carlo ligand generation.
TLDR
A new computational method for the in situ generation of small molecules within the binding site of a protein is described, which resulted in a compound selected for preclinical studies as an antiviral agent against AIDS. Expand
Active Learning with Support Vector Machines in the Drug Discovery Process
TLDR
A thorough comparative study of various other selection strategies on data sets provided by DuPont Pharmaceuticals is performed and it is shown that the strategies based on the maximum margin hyperplane clearly outperform the simpler ones. Expand
Pharmacophore Discovery - Lessons Learned
TLDR
The experiences of over a decade of confronting and solving the challenges of pharmacophore discovery applied to actual drug discovery are summarized and practical tips are described for using the author's methodology, DANTE. Expand
Pushing the boundaries of 3D-QSAR
TLDR
Predictive r2 values from an exploratory new “series trajectory” analysis of these 3D-QSAR though highly variable do not differ much from their q2 values, a phenomenon that seems to encourage prediction even when there are so few structures underlying a 3D, QSAR so that almost all information is unique. Expand
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
TLDR
A pharmacophore for QT-prolonging drugs, along with a 3D QSAR (CoMFA) study for a series of very structurally variegate HERG K(+) channel blockers, and a theoretical screening tool able to predict whether a new molecule can interact with the HERG channel and eventually induce the long QT syndrome. Expand
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poorExpand
Discovering High-Affinity Ligands for Proteins: SAR by NMR
TLDR
A nuclear magnetic resonance (NMR)-based method is described in which small organic molecules that bind to proximal subsites of a protein are identified, optimized, and linked together to produce high-affinity ligands and appears particularly useful in target-directed drug research. Expand
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.
TLDR
The main features of the CoMFA approach, exemplified by analyses of the affinities of 21 varied steroids to corticosteroid and testosterone-binding globulins, and a number of advances in the methodology of molecular graphics are described. Expand
Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches.
A data set consisting of twenty-two sertindole analogues and ten structurally diverse inhibitors, spanning a wide range in potency, was analyzed using CoMSiA. A homology model of HERG was constructedExpand
...
1
2
3
4
5
...